MENU
SUPN
AS OF
Dec 24 closing price
Price
$51.77
Change
+$0.06 (+0.12%)
Capitalization
2.97B
68 days until earnings call
Intraday BUY SELL Signals
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2025 All rights reserved. Tickeron Inc.
SUPN
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Supernus Pharmaceuticals (SUPN) Ownership - Who owns Supernus Pharmaceuticals?

Supernus Pharmaceuticals Inc is a specialty pharmaceutical company... Show more

#MovingAverage#Momentum#MACD#Pattern#RSI#Stochastic#Aroon#Bollinger

Profile

Industry
Pharmaceuticals Other
Address
9715 Key West Avenue
Phone
+1 301 838-2500
Employees
652
Web
https://www.supernus.com

Details

Group
Domestic Stock Funds
Category
Pharmaceuticals
Capitalization
2.97B
P/E Ratio
49.57
Total Cash
281.16M
Projected Growth
N/A
Total Debt
42.21M
Revenue
681.54M
Risk (Beta)
1.13
Dividend Yield
N/A
Total Cash/Share
4.90
Total Debt/Equity
97.74
Revenue/Share
12.12 USD as % of share price

Fundamentals

SUPN
Capitalization
2.97B
P/E Ratio
49.57
Risk (Beta)
1.13
Dividend Yield
N/A
Total Cash
281M
Total Cash/Share
4.90
Total Debt
42.2M
Total Debt/Equity
97.74
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
12.12%
Revenue
682M
ROE
N/A
Book Value
1.05B
P/B Ratio
2.83
Cash Flow
N/A
Earnings
-0.33
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
57K
Current Ratio
1.80
Current Revenue Per Employee
285019.28
Dividends Per Share - Security
N/A
EBITDA
78.8M
Float
N/A
Float - Current
N/A
Gross Income Margin
90.13
Revenue To Assets
-1.38
Shares Held By Institutions
6.49B
Shares Outstanding - Current
57.3M
Total Liabilities
370M
Total Volume MTD
N/A
Value
-1
Gain YTD
43.169
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
SUPN
Setup
Setup
Daily Signal:
Description
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. SUPN showed earnings on November 04, 2025. You can read more about the earnings report here.
View AI-Driven Trading for SUPN
A.I. Advisor
published General Information

General Information

a developer for the treatment of central nervous system

Industry PharmaceuticalsGeneric

Profile
Fundamentals
Details
Industry
Pharmaceuticals Other
Address
9715 Key West Avenue
Phone
+1 301 838-2500
Employees
652
Web
https://www.supernus.com